Overview
Human-data-first AI drug discovery and development company.
Details
Valo’s Opal platform combines patient data, ML, and chemistry. Programs in cardiometabolic disease, oncology, and CNS.
Human-data-first AI drug discovery and development company. Valo's Opal platform combines patient data, ML, and chemistry. Programs in cardiometabolic disease, oncology, and CNS.
Human-data-first AI drug discovery and development company.
Valo’s Opal platform combines patient data, ML, and chemistry. Programs in cardiometabolic disease, oncology, and CNS.